ArticleCancer innovation2025

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition).

Breast Cancer Expert Committee of the National Quality Control Center for Cancer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.